U.S. flag

An official website of the United States government

NM_000515.5(GH1):c.291+2T>C AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 16, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000711802.3

Allele description [Variation Report for NM_000515.5(GH1):c.291+2T>C]

NM_000515.5(GH1):c.291+2T>C

Genes:
GH1:growth hormone 1 [Gene - OMIM - HGNC]
GH-LCR:growth hormone locus control region [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
17q23.3
Genomic location:
Preferred name:
NM_000515.5(GH1):c.291+2T>C
HGVS:
  • NC_000017.11:g.63918015A>G
  • NG_011676.1:g.5824T>C
  • NG_042788.1:g.923A>G
  • NM_000515.5:c.291+2T>CMANE SELECT
  • NM_022559.4:c.246+2T>C
  • NM_022560.4:c.172-91T>C
  • NC_000017.10:g.61995375A>G
  • NM_000515.3:c.291+2T>C
  • NM_000515.4:c.291+2T>C
Note:
NCBI staff reviewed the sequence information reported in PubMed 12574219 Fig. 3 to determine the location of this allele on the current reference sequence.
Nucleotide change:
IVS3DS, T-C, +2
Links:
OMIM: 139250.0019; dbSNP: rs863223310
NCBI 1000 Genomes Browser:
rs863223310
Molecular consequence:
  • NM_022560.4:c.172-91T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000515.5:c.291+2T>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_022559.4:c.246+2T>C - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000842205Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics Criteria)
Pathogenic
(Feb 16, 2018)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Isolated autosomal dominant growth hormone deficiency: stimulating mutant GH-1 gene expression drives GH-1 splice-site selection, cell proliferation, and apoptosis.

Salemi S, Yousefi S, Lochmatter D, Eblé A, Deladoëy J, Robinson IC, Simon HU, Mullis PE.

Endocrinology. 2007 Jan;148(1):45-53. Epub 2006 Oct 12.

PubMed [citation]
PMID:
17038549

Rescue of Isolated GH Deficiency Type II (IGHD II) via Pharmacologic Modulation of GH-1 Splicing.

Miletta MC, Petkovic V, Eblé A, Flück CE, Mullis PE.

Endocrinology. 2016 Oct;157(10):3972-3982. Epub 2016 Jun 2.

PubMed [citation]
PMID:
27253996
See all PubMed Citations (10)

Details of each submission

From Athena Diagnostics, SCV000842205.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024